Adriamycin pfs and Carbamazepine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Adriamycin pfs and Carbamazepine together.

The phase IV clinical study analyzes what interactions people who take Adriamycin pfs and Carbamazepine have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

3 people who take Adriamycin pfs and Carbamazepine together, and have interactions are studied.


What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users for its effectiveness, alternative drugs and more.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 39,566 Carbamazepine users for its effectiveness, alternative drugs and more.

Number of Adriamycin pfs and Carbamazepine reports submitted per year:

Adriamycin pfs and Carbamazepine drug interactions.

Common Adriamycin Pfs and Carbamazepine drug interactions by gender *:

female:

  1. Acute leukaemia
  2. Grand mal convulsion
  3. Metastases to brain
  4. Thrombocytopenia
  5. White blood cell count increased

male:

  1. Pancytopenia
  2. Retinal haemorrhage

Common Adriamycin Pfs and Carbamazepine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Grand mal convulsion

40-49:

n/a

50-59:

  1. Acute leukaemia
  2. Metastases to brain
  3. Pancytopenia
  4. Retinal haemorrhage
  5. Thrombocytopenia
  6. White blood cell count increased

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Adriamycin pfs and Carbamazepine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Adriamycin pfs and Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adriamycin pfs interactions:

Browse all interactions between Adriamycin pfs and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Carbamazepine interactions:

Browse all interactions between Carbamazepine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride and carbamazepine (the active ingredients of Adriamycin pfs and Carbamazepine, respectively), and Adriamycin pfs and Carbamazepine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Adriamycin pfs and Carbamazepine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: